Biddle Warner Weston
SEC insider (Form 3/4/5 filer). CIK 0002034523. Chief Executive Officer at Kyverna Therapeutics, Inc. (KYTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 13, 2026. Located in EMERYVILLE, CA.
Companies Biddle Warner Weston has filed insider reports for
- Kyverna Therapeutics, Inc. (KYTX): Director, Officer, Chief Executive Officer
Biddle Warner Weston
CIK: 0002034523
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KYTX
Kyverna Therapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 13, 2026KYTX
Kyverna Therapeutics, Inc.
AwardDirect58K shares- - Sep 16, 2024KYTX
Kyverna Therapeutics, Inc.
AwardDirectStock Option (right to buy)
2.6M shares- - Apr 11, 2024KYTX
Kyverna Therapeutics, Inc.
AwardDirectStock Option (right to buy)
332.5K shares-
1-3 of 3 transactions